Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PSBD
PSBD logo

PSBD Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Palmer Square Capital BDC Inc (PSBD) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
9.800
1 Day change
1.34%
52 Week Range
14.970
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Palmer Square Capital BDC Inc (PSBD) is not a good buy for a beginner investor with a long-term strategy at this time. The stock lacks positive catalysts, has weak financial performance, and no strong trading signals. Analysts have lowered price targets, and there are no recent significant insider or hedge fund activities to suggest confidence in the stock. While the technical indicators are mixed, the bearish moving averages and lack of upward momentum do not support a strong buy case.

Technical Analysis

The MACD is slightly positive and expanding, indicating mild bullish momentum. However, the RSI is neutral at 50.432, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support and resistance levels suggest limited upside potential in the short term, with resistance at 10.835 and support at 10.247.

Positive Catalysts

  • NULL identified. No recent news or significant insider/hedge fund activity. Technical indicators show mild bullish momentum but are not strong enough to act as a catalyst.

Neutral/Negative Catalysts

  • Analysts have consistently lowered price targets, citing constrained credit opportunities and lower multiples. Financial performance in Q4 2025 was extremely weak, with significant drops in revenue, net income, and EPS. No recent news or influential trading activity to suggest a turnaround.

Financial Performance

In Q4 2025, revenue dropped by -64.22% YoY to $11,446,545. Net income fell by -144.50% YoY to -$5,303,919, and EPS declined by -145.95% YoY to -0.17. The company's gross margin remained at 0%. These metrics indicate significant financial struggles.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have downgraded their price targets multiple times recently. UBS lowered its target to $11.50 from $13, JPMorgan reduced it to $10 from $11.50, and RBC Capital adjusted its target to $12 from $13. All analysts maintain neutral or sector perform ratings, reflecting a lack of confidence in the stock's near-term prospects.

Wall Street analysts forecast PSBD stock price to rise
3 Analyst Rating
Wall Street analysts forecast PSBD stock price to rise
0 Buy
3 Hold
0 Sell
Hold
Current: 9.670
sliders
Low
12.5
Averages
12.83
High
13
Current: 9.670
sliders
Low
12.5
Averages
12.83
High
13
UBS
Doug Harter
Neutral
downgrade
$13
AI Analysis
2026-03-13
Reason
UBS
Doug Harter
Price Target
$13
AI Analysis
2026-03-13
downgrade
Neutral
Reason
UBS analyst Doug Harter lowered the firm's price target on Palmer Square to $11.50 from $13 and keeps a Neutral rating on the shares.
JPMorgan
Neutral
downgrade
$10
2026-03-13
Reason
JPMorgan
Price Target
$10
2026-03-13
downgrade
Neutral
Reason
JPMorgan lowered the firm's price target on Palmer Square to $10 from $11.50 and keeps a Neutral rating on the shares. The firm reduced targets in the business development company space to reflect lower multiples and "higher scrutiny."
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PSBD
Unlock Now

People Also Watch